IQVIA (IQV) Stock Price & Analysis

IQV$263.79—
Medical - Diagnostics & ResearchLarge CapGrowth Stock
Compare
Market cap$40.51BEnterprise value—Revenue (TTM)$17.31BMarket positionTop 25%

Score

47
Neutral
Value
44
Quality
37
Growth
60

AI Analysis

Snapshot

IQVIA Holdings is a mixed profile at 47/100 — Value 44, Growth 60, Quality 37. Under the hood: P/E 31.7, about 43% below its own multi-year median, plus revenue compounding ~4% annually over recent years.

Price History

Bullish (65+)Neutral (45–64)Bearish (<45)

Score Breakdown

Market percentile scores loading…

Value

44
PE Ratio (F)–
PEG Ratio–
Free Cashflow Yield %–
EV/EBITDA Ratio–
Discount vs All Time Peak–
Discount vs 1Y Peak–

Growth

60
Earnings Forecast–
Last 3M Earnings Growth %–
12M Revenue Growth %–
12M Earnings Growth %–
5 YR CAGR % Earnings–
Analyst Price Forecast–

Quality

37
FCF Margin %–
Net Debt / EBITDA–
Operating Margin %–
Operating Margin Growth %–
ROCE %–
Current Ratio–

Financial Summary

IQVIA Holdings Inc. (IQV) last printed $263.79. Equity value is $40.51B. Trailing earnings multiple 29.62. The revenue row is reported history. Targets and ratings are on the forecast page.

Financials

2016201720182019202020212022202320242025
$6.82B$9.7B$10.41B$11.09B$11.36B$13.87B$14.41B$14.98B$15.4B$16.31B

About

IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.

IQVIA (IQV) Stock Price & Analysis

IQV price $263.79 —

Ticker
IQV
Price
$263.79
Change
—
Market cap
$40.51B
P/E
29.62
Forward P/E
18.18
Dividend yield
0.00%
Beta
1.16
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Stocklytics score
47
Value
44
Quality
37
Growth
60

Stocklytics score rationale: value 44, quality 37, growth 60.

AI Score 70. IQVIA Holdings Inc. has a market cap of $44.06 billion and a price of $267.33, with a price-to-earnings ratio of 32.1, indicating a premium valuation

Fair value

IQV fair value $326.45. Price $263.79. Price is 19% below fair value.

Below fair value, and cheaper than usual. A larger discount than on more than 99% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price.

Fair value blends a 10-year DCF and an earnings multiple: the average of the DCF value and an earnings value from next-twelve-months EPS times 30.0, a blend of the Medical - Diagnostics & Research median (33.2) and the stock's own 10-year median (45.5). How we calculate it →

Compare IQV

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2027-02-04—3.60—4.53B
2026-10-273.343.264.43B4.37B
2026-07-283.153.034.37B4.30B
2026-05-052.902.824.15B4.10B
2026-02-053.423.404.36B4.24B
2025-10-283.002.984.10B4.08B
2025-07-222.812.774.02B3.97B
2025-05-062.702.633.83B3.77B
2025-02-063.123.113.96B3.93B
2024-10-312.842.823.90B3.87B
2024-07-222.642.563.81B3.79B
2024-05-022.542.493.74B3.70B
2024-02-142.842.823.91B3.80B
2023-11-012.492.463.74B3.78B
2023-08-012.432.373.73B3.71B
2023-04-272.452.413.65B3.61B
2023-02-102.782.753.74B3.71B
2022-10-262.482.393.56B3.54B
2022-07-212.442.393.54B3.49B
2022-04-272.472.433.57B3.54B
2022-02-152.552.433.64B3.59B
2021-10-212.172.133.39B3.35B
2021-07-272.132.073.44B3.35B
2021-04-222.181.853.41B3.17B
2021-02-102.112.013.30B3.14B
2020-10-201.631.512.79B2.63B
2020-07-221.181.052.52B2.26B
2020-04-281.501.482.75B2.72B
2020-02-121.741.722.90B2.86B
2019-10-301.601.572.77B2.72B
2019-07-241.531.492.74B2.67B
2019-05-011.531.512.68B2.65B
2019-02-141.501.472.69B2.63B
2018-10-221.421.392.59B2.54B
2018-07-241.291.242.57B2.45B
2018-05-021.341.282.56B2.43B
2018-02-141.401.342.58B2.41B
2017-10-261.191.142.46B2.36B
2017-08-031.091.052.38B2.27B
2017-05-031.010.962.32B2.24B

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-11-09Sherbet EricExempt8.44K$131.821.11M
2026-11-09Sherbet EricSell4.45K$278.831.24M
2026-11-09Sherbet EricSell3.99K$278.741.11M
2026-11-09Sherbet EricExempt8.44K$131.821.11M
2026-11-05Wims Morris LeslieAward125$264.8833.11K
2026-11-05GOGGINS COLLEEN AAward144$264.8838.14K
2026-11-05Fasano JimAward154$264.8840.79K
2026-11-05DANHAKL JOHN GAward134$264.8835.49K
2026-09-02Berkshire James G.Exempt5.38K$131.82709.32K
2026-09-02Berkshire James G.Sell2.67K$261.33697.23K
2026-09-02Berkshire James G.Sell2.71K$261.54709.56K
2026-09-02Berkshire James G.Exempt5.38K$131.82709.32K
2026-08-03STAUB W RICHARDSell5.50K$232.681.28M
2026-07-31Patel BhavikSell1.85K$235.27436.43K
2026-07-29Sherbet EricSell5.00K$249.161.25M
2026-07-29Cherofsky KeriannSell558$245.21136.83K
2026-07-29BOUSBIB ARIExempt156.21K$78.2112.22M
2026-07-29BOUSBIB ARISell4.46K$247.101.10M
2026-07-29BOUSBIB ARISell4.58K$246.851.13M
2026-07-29BOUSBIB ARISell44.04K$246.0810.84M
2026-07-29BOUSBIB ARISell53.19K$244.7813.02M
2026-07-29BOUSBIB ARISell47.86K$244.6011.71M
2026-07-29BOUSBIB ARISell2.07K$247.00511.04K
2026-07-29BOUSBIB ARIExempt156.21K$78.2112.22M
2026-07-14Wims Morris LeslieAward148$207.8330.76K
2026-07-14GOGGINS COLLEEN AAward183$207.8338.03K
2026-07-14Fasano JimAward195$207.8340.53K
2026-07-14DANHAKL JOHN GAward160$207.8333.25K
2026-05-07Wims Morris LeslieAward171——
2026-05-07GOGGINS COLLEEN AAward214——
2026-05-07Fasano JimAward228——
2026-05-07DANHAKL JOHN GAward185——
2026-04-23Stamps Sheila AAward1.57K——
2026-04-23Wims Morris LeslieAward1.57K——
2026-04-23Kaelin William G JrAward1.57K——
2026-04-23LEONARD JOHN MAward1.57K——
2026-04-23GOGGINS COLLEEN AAward1.57K——
2026-04-23Fasano JimAward1.57K——
2026-04-23DANHAKL JOHN GAward1.57K——
2026-04-23Burt CarolAward1.57K——
2026-02-13Haas BerndInkind20$166.943.34K
2026-02-13Fedock Michael J.Inkind123$166.9420.53K
2026-02-09STAUB W RICHARDAward26.09K$192.675.03M
2026-02-09Sherbet EricAward12.11K$192.672.33M
2026-02-09Patel BhavikAward11.18K$192.672.15M
2026-02-09Haas BerndAward11.18K$192.672.15M
2026-02-09Grenfell AlistairAward26.09K$192.675.03M
2026-02-09Fedock Michael J.Award18.63K$192.673.59M
2026-02-09Cherofsky KeriannAward2.79K$192.67538.51K
2026-02-09Berkshire James G.Award11.18K$192.672.15M
2026-02-09BOUSBIB ARIAward78.26K$192.6715.08M
2026-02-09Wims Morris LeslieAward159——
2026-02-09GOGGINS COLLEEN AAward198——
2026-02-09Fasano JimAward211——
2026-02-09DANHAKL JOHN GAward172——
2026-02-08Haas BerndAward8.27K——
2026-02-08Haas BerndInkind440$187.4982.50K
2026-02-08Grenfell AlistairAward11.79K——
2026-02-08Grenfell AlistairInkind5.54K$187.491.04M
2026-02-08Fedock Michael J.Award6.74K——
2026-02-08Fedock Michael J.Inkind2.42K$187.49453.73K
2026-02-08Patel BhavikAward4.08K——
2026-02-08Patel BhavikInkind1.92K$187.49359.98K
2026-02-08Sherbet EricAward6.81K——
2026-02-08Sherbet EricInkind1.92K$187.49359.04K
2026-02-08STAUB W RICHARDAward2.72K——
2026-02-08STAUB W RICHARDInkind806$187.49151.12K
2026-02-08Cherofsky KeriannAward1.09K——
2026-02-08Cherofsky KeriannInkind415$187.4977.81K
2026-02-08Bruehlman Ronald EAward16.34K——
2026-02-08Bruehlman Ronald EInkind6.80K$187.491.28M
2026-02-08Berkshire James G.Award2.72K——
2026-02-08Berkshire James G.Inkind1.28K$187.49239.99K
2026-02-08BOUSBIB ARIAward57.18K——
2026-02-08BOUSBIB ARIInkind28.40K$187.495.32M
2026-02-07Fedock Michael J.Inkind111$187.4920.81K
2026-01-28Fedock Michael J.Inkind381$239.7691.35K
2025-12-31Haas BerndOther0——
2025-12-31Haas BerndOther0$203.430
2025-12-31Haas BerndOther0$214.340
2025-12-31Haas BerndOther0$232.110
2025-12-31Grenfell AlistairOther0$203.430
2025-12-31Grenfell AlistairOther0——
2025-12-31Grenfell AlistairOther0$214.340
2025-12-31Grenfell AlistairOther0$232.110
2025-12-31Fedock Michael J.Other0$203.430
2025-12-31Fedock Michael J.Other0——
2025-12-31Fedock Michael J.Other0$214.340
2025-12-31Fedock Michael J.Other0$232.110
2025-12-31Berkshire James G.Other0$203.430
2025-12-31Berkshire James G.Other0——
2025-02-10Haas BerndOther0$250.430
2025-02-10Grenfell AlistairOther0$250.430
2025-02-10Fedock Michael J.Other0$250.430
2024-02-09Haas BerndOther0$183.820
2024-02-09Fedock Michael J.Other0$183.820
2023-02-11Haas BerndOther0$161.700
2023-02-11Berkshire James G.Other0$161.700
2022-02-13Haas BerndOther0$131.820
2021-02-08Haas BerndOther0$95.230

Institutional holders

Latest filed quarter: Q3 2026.

Institutions holding: 1.03K, holders -99 vs prior quarter. Ownership 68.01%.

HolderSharesChangeChange %Value
BLACKROCK, INC.14.43M-116.40K−0.80%3.88B
VANGUARD CAPITAL MANAGEMENT LLC10.78M-127.60K−1.17%2.90B
STATE STREET CORP7.52M8.25K+0.11%2.02B
VANGUARD PORTFOLIO MANAGEMENT LLC7.36M-139.57K−1.86%1.98B
GEODE CAPITAL MANAGEMENT, LLC4.43M-28.64K−0.64%1.19B
BOSTON PARTNERS4.37M-97.26K−2.18%1.17B
JPMORGAN CHASE & CO4.32M-1.82M−29.69%1.16B
ARTISAN PARTNERS LIMITED PARTNERSHIP3.46M-1.28M−27.03%930.59M
INVESCO LTD.2.94M-331.90K−10.13%791.29M
MORGAN STANLEY2.68M-24.46K−0.90%721.27M
WCM INVESTMENT MANAGEMENT, LLC2.67M2.67MNew717.70M
FMR LLC2.10M892.15K+73.57%565.88M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP1.90M653.23K+52.26%511.70M
DIMENSIONAL FUND ADVISORS LP1.80M69.49K+4.00%485.25M
FRANKLIN TEMPLETON INC1.53M-575.53K−27.34%403.51M
LONGVIEW PARTNERS (GUERNSEY) LTD1.26M-244.33K−16.28%337.79M
LYRICAL ASSET MANAGEMENT LP1.25M-6.10K−0.48%337.08M
JANE STREET GROUP, LLC1.01M1.01MNew272.29M
RAYMOND JAMES FINANCIAL INC999.57K-37.86K−3.65%268.73M
DEUTSCHE BANK AG\955.15K214.68K+28.99%256.79M
VANGUARD FIDUCIARY TRUST CO929.03K-8.31K−0.89%249.77M
FIL LTD898.75K79.76K+9.74%241.63M
BANK OF NEW YORK MELLON CORP894.40K-38.71K−4.15%240.46M
AMERICAN CENTURY COMPANIES INC850.11K-209.42K−19.77%228.55M
AMUNDI801.48K-156.31K−16.32%215.48M
SUMITOMO MITSUI TRUST GROUP, INC.782.84K-48.99K−5.89%210.47M
KBC GROUP NV739.78K-8.19K−1.10%198.89M
MANUFACTURERS LIFE INSURANCE COMPANY, THE628.71K-223−0.04%169.03M
EARNEST PARTNERS LLC549.71K549.71KNew147.79M
GREENHAVEN ASSOCIATES INC544.92K-223.12K−29.05%146.50M
1832 ASSET MANAGEMENT L.P.532.77K-211.47K−28.41%143.24M
QUANTINNO CAPITAL MANAGEMENT LP486.20K486.20KNew130.72M
NUVEEN, LLC482.29K482.29KNew129.66M
CIBC BANCORP USA INC.479.46K-267.57K−35.82%128.96M
UBS GROUP AG464.32K464.32KNew124.83M
SWISS NATIONAL BANK456.48K456.48KNew122.72M
MITSUBISHI UFJ ASSET MANAGEMENT CO., LTD.427.34K427.34KNew114.89M
PGGM INVESTMENTS424.04K424.04KNew114.00M
EDMOND DE ROTHSCHILD HOLDING S.A.403.48K403.48KNew108.48M
HRT FINANCIAL LP397.07K397.07KNew106.75M
LORD, ABBETT & CO. LLC389.97K389.97KNew104.84M
NATIONAL PENSION SERVICE379.89K379.89KNew102.13M
VANGUARD GLOBAL ADVISERS, LLC364.42K364.42KNew97.98M
MARSHALL WACE, LLP353.90K353.90KNew95.15M
VANGUARD ASSET MANAGEMENT, LTD346.04K346.04KNew93.03M
SOUND SHORE MANAGEMENT INC /CT/338.67K338.67KNew91.05M
BNP PARIBAS FINANCIAL MARKETS332.96K332.96KNew89.52M
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO326.99K326.99KNew87.91M
ASSENAGON ASSET MANAGEMENT S.A.326.42K326.42KNew87.76M
CAPITAL WORLD INVESTORS320.66K320.66KNew86.21M

Insights · Forecast · Financials · Learn

Stocklytics home · Screener